Rowan EG, Harvey AL (2011)
Snake Toxins from Mamba Venoms: Unique Tools for the Physiologist
Acta Chim Slov 58: 689
Jalali A, Vatanpour H, Hosseininasab Z, Rowan EG, Harvey AL (2007)
The effect of the venom of the yellow Iranian scorpion Odontobuthus doriae on skeletal muscle preparations in vitro
Toxicon 50: 1019
Bradley KN, Rowan EG, Harvey AL (2003)
Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells
Toxicon 41: 207
Fatehi M, Rowan EG, Harvey AL (2002)
An electrophysiological study on the effects of Pa-1G (a phospholipase A(2)) from the venom of king brown snake, Pseudechis australis, on neuromuscular function
Toxicon 40: 69
Bradley KN, Rowan EG, Harvey AL (2001)
Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation
Toxicon 39: 581
Fathi HB, Rowan EG, Harvey AL (2001)
The facilitatory actions of snake venom phospholipase A(2) neurotoxins at the neuromuscular junction are not mediated through voltage-gated K(+) channels
Toxicon 39: 1871
Fatani AJ, Harvey AL, Furman BL, Rowan EG (2000)
The effects of lignocaine on actions of the venom from the yellow scorpion Leiurus quinquestriatus in vivo and in vitro
Toxicon 38: 1787
Harvey AL, Bradley KN, Cochran SA, Rowan EG, Pratt JA, Quillfeldt JA, Jerusalinsky DA (1998)
What can toxins tell us for drug discovery?
Toxicon 36: 1635
Fatehi M, Rowan EG, Harvey AL, Moya E, Blagbrough IS (1997)
Polyamine FTX-3.3 and polyamine amide sFTX-3.3 inhibit presynaptic calcium currents and acetylcholine release at mouse motor nerve terminals
Neuropharmacology 36: 185
Henning RH, Rowan EG, Braga MF, Nelemans A, Harvey AL (1996)
The prejunctional inhibitory effect of suramin on neuromuscular transmission in vitro
European Journal of Pharmacology 301: 91
Alzahaby M, Rowan EG, Young LC, al-Zahaby AS, Abu-Sinna G, Harvey AL (1995)
Some pharmacological studies on the effects of Cerastes vipera (Sahara sand viper) snake venom
Toxicon 33: 1299
Braga MF, Rowan EG, Harvey AL (1995)
Modification of ionic currents underlying action potentials in mouse nerve terminals by the thiol-oxidizing agent diamide
Neuropharmacology 34: 1529
Fatehi M, Rowan EG, Harvey AL (1995)
The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake
Toxicon 33: 1633
Braga MF, Rowan EG, Harvey AL, Bowman WC (1994)
Interactions between suxamethonium and non-depolarizing neuromuscular blocking drugs
British Journal of Anaesthesia 72: 198
Fatehi M, Rowan EG, Harvey AL, Harris JB (1994)
The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle
Toxicon 32: 1559
Braga MF, Rowan EG, Harvey AL, Bowman WC (1993)
Prejunctional action of neostigmine on mouse neuromuscular preparations
British Journal of Anaesthesia 70: 405
Braga MF, Harvey AL, Rowan EG (1991)
Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro
British Journal of Pharmacology 102: 909
Ducancel F, Rowan EG, Cassar E, Harvey AL, Menez A, Boulain JC (1991)
Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence
Toxicon 29: 516
Harvey AL, Rowan EG (1990)
Effects of tacrine, aminopyridines, and physostigmine on acetylcholinesterase, acetylcholine release, and potassium currents
Advances in Neurology 51: 227
Rowan EG, Pemberton KE, Harvey AL (1990)
On the blockade of acetylcholine release at mouse motor nerve terminals by beta-bungarotoxin and crotoxin
British Journal of Pharmacology 100: 301
Rowan EG, Harvey AL, Takasaki C, Tamiya N (1989)
Neuromuscular effects of three phospholipases A2 from the venom of the Australian king brown snake Pseudechis australis
Toxicon 27: 551
Anderson AJ, Harvey AL, Rowan EG, Strong PN (1988)
Effects of charybdotoxin, a blocker of Ca2+-activated K+ channels, on motor nerve terminals
British Journal of Pharmacology 95: 1329